October 2024
Cochlear-backed medtech Epiminder seeks $200m val in pre-IPO raise
The company expects its implants to be commercially available in the US market in 2027.
June 2024
How this Australian banker thrived on Wall Street for 30 years
Queenslander Paul Compton, who started a job at Jamie Dimon’s JP Morgan in 2007, knows that the industry can be a rough ride.
October 2020
Cochlear-backed medical devices outfit closes $18m Series A round
ASX-listed hearing device behemoth Cohclear has reached into its pocket again to finance the growth of a Melbourne-based medical devices start-up.